Currently, out of the existing stock ratings of Jason Mills - 200 which are a Buy (82.99%), 41 which are a Hold (17.01%)

Jason Mills

Work Performance Price Targets & Ratings Chart

Analyst Jason Mills works at CANACCORD and is covering the Healthcare sector with 459 price targets and ratings displayed on 21 stocks.

Jason Mills's average stock forecast success ratio is 85.56% with an average time for price targets to be met of 226.68 days.

Most recent stock forecast was given on STAA, STAAR Surgical Company at 03-Aug-2023.

Wall Street Analyst Jason Mills

Analyst best performing recommendations are on STIM (NEURONETICS).
The best stock recommendation documented was for VAPO (VAPOTHERM) at 3/5/2020. The price target of $14 was fulfilled within 11 days with a profit of $3.85 (37.93%) receiving and performance score of 34.48.

Average potential price target upside

of $16.63 (14.82%) on PEN (PENUMBRA).
of $11.53 (11.08%) on ISRG (INTUITIVE SURGICAL).
of $23.37 (31.83%) on NVRO (NEVRO).

BSX Boston Scientific EW Edwards Lifesciences IRT ISRG Intuitive Surgical LMAT LeMaitre Vascular NVRO Nevro STAA STAAR Surgical Company PEN Penumbra TCMD Tactile Systems Technology LIVN LivaNova PLC VAPO Vapotherm AORT CRY CryoLife SWAV ShockWave Medical MMSI Merit Medical Systems ANGO AngioDynamics ATRC AtriCure NVCN STIM Neuronetics TEF TMDX TransMedics Group

Show more stocks

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Matt Miksic (CREDIT SUISSE)